Hepatoma Research
All Journals
Search Log In
Home Articles Special Topics Volumes Webinars Interviews
Hepatoma Research
Search Submit
Home Articles Special Topics Volumes Webinars Interviews

fig2

From:  Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists - mechanisms, clinical evidence, and therapeutic perspectives
Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists - mechanisms, clinical evidence, and therapeutic perspectives

Figure 2. Tissue specific processing of preproglucagon. This image was created by us with Canva. SP: Signal peptide; GRPP: glicentin-related pancreatic polypeptide; IP-1: intervening peptide 1; GLP-1: glucagon-like peptide-1; IP-2: intervening peptide 2; GLP-2: glucagon-like peptide-2. MPGF: major proglucagon fragment.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/hepatoma-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties